forbot
India
Geftinat 250 mg tablets (Anti Cancer Drug) buy in Nagpur
Currency INR
Geftinat 250 mg tablets (Anti Cancer Drug) buy in Nagpur
Buy Geftinat 250 mg tablets (Anti Cancer Drug)
Geftinat 250 mg tablets (Anti Cancer Drug)

Geftinat 250 mg tablets (Anti Cancer Drug)

Products from producer
Check availability
Reconfirm the price with seller
0UAH
Do you have any questions about the product/service?
Please, leave your inquiry and company manager will contact you.
India, Nagpur
Technical characteristics
  • BrandGeftinat
  • Country of manufactureIndia
  • Geftinatgefitinib
  • Brand Namegeftinat
  • Containsgefitinib
  • Strengthgeftinat 250 mg tablets
Description
we are occupied in offering premium quality Geftinib Tablet. Used under proper medical guidance and advice, these tablets are commonly used for the treatment of cancer. Our offered tablets are broadly applauded by our valued clients sprawled across the nation. In order to facilitate safer deliveries, these tablets are available in qualitative packaging options.

Features:
  • Purity
  • Accurate composition
  • Reliable usage

Specifications:
  • Geftinat - gefitinib
  • Brand name: geftinat
  • Contains: gefitinib
  • Strength: geftinat 250 mg tablets
  • 1 bottle of geftinat contains 30 tablets

Note: Geftinat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Contact the seller
Geftinat 250 mg tablets (Anti Cancer Drug)
Geftinat 250 mg tablets (Anti Cancer Drug)
View also products categories "Antineoplastic and immunomodulating medications (L)"
for
by the goods
Your message must contain at least 20 symbols. The message must not be more than 2000 symbols.
Obligatory field is not filled
The field is wrongly filled
The field is wrongly filled
Compare0
ClearSelected items: 0
    Placing, selling, advertising and/or realization of this service/product is prohibited by operating legislation. Go to main page